`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`NUVASIVE, INC.
`Petitioner
`
`v.
`
`WARSAW ORTHOPEDICS, INC.
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2013-00395
`Patent 8,444,696
`
`
`
`
`
`
`
`
`
`
`
`
`PETITIONER’S RESPONSE TO THE MOTION FOR OBSERVATION REGARDING
`CROSS-EXAMINATION OF DR. BRANTIGAN
`
`
`
`Case IPR2013-00395
`Attorney Docket No: 13958-113IP1
`
`Response to the Introduction
`
`This paper responds to Patent Owner’s motion for observation regarding cross-
`
`examination of Dr. Brantigan, filed June 26, 2014. Patent Owner states in an introductory
`
`paragraph that it filed its observations about “Dr. Brantigan’s prior sworn testimony” “[i]n lieu
`
`of taking additional depositions.” However, Petitioner made Dr. Brantigan available to
`
`Patent Owner for deposition. It was Patent Owner’s choice to comment on Dr. Brantigan’s
`
`prior testimony and to forgo a deposition in which Dr. Brantigan could explain that the
`
`supposed inconsistencies do not exist. Petitioner disagrees with Patent Owner’s
`
`characterization of Dr. Brantigan’s prior testimony as explained below.
`
`Response to Observation No. 1
`
`
`
`In Observation No. 1, Patent Owner discusses Dr. Brantigan’s prior testimony
`
`concerning the addition of ratchetings to the Senter implant. According to Patent Owner Dr.
`
`Brantigan, in paragraphs 8 and 9, “now ignores” the resistance to insertion of the modified
`
`implant. But Patent Owner does not take into account Dr. Brantigan’s testimony in
`
`paragraph 7 of the declaration which explains that during implantation the patients weight is
`
`not on the vertebra and the vertebra may be distracted lessening any resistance during
`
`insertion. Dr. Brantigan provided the same explanation at testimony in his deposition
`
`testimony. See Exhibit 2009 at page 85, line 22 to page 86, line 3. No inconsistency exists.
`
`
`
`
`
`2
`
`
`
`Case IPR2013-00395
`Attorney Docket No: 13958-113IP1
`
`Response to Observation Nos. 2-3
`
`In Observation Nos. 2-3, Patent Owner discusses Dr. Brantigan’s prior testimony
`
`concerning the placement and potential “scraping off” of fusion material in the modified
`
`Senter implant. No contradiction is apparent when reading the Patent Owner’s quotes from
`
`the declaration and the deposition testimony.
`
`Patent Owner selectively crops Dr. Brantigan’s deposition testimony to create the
`
`illusion of contradiction. Dr. Brantigan’s full answer at deposition is Exhibit 2009 at page 92,
`
`line 21 to page, lines 12-15:
`
`A. It’s hard for me to understand your distinctions, because
`you would put as much bone in there as you could. That
`bone would be tending to bulge out beyond the confines of
`the implant. During the placement, some of that bone will
`be scraped off, and then you can pack that beside the
`implant. But after the bone that’s still in there has some
`time for the sponginess to expand, it will expand to the limits
`of the implant and have good apposition against the
`vertebral endplates.
`Consistently, Dr. Brantigan testified at page 96, lines 6-12 of Exhibit 2009:
`
`A. I think we are saying the same thing over and over again. I believe that
`
`some of the bone will be scraped off. But enough of the bone would
`
`remain in there. Particularly, if you’ve compressed cancellous bone,
`
`3
`
`
`
`Case IPR2013-00395
`Attorney Docket No: 13958-113IP1
`you’ve scraped some of it off, and the rest of it tends to return to its
`
`uncompressed height once it’s in place.
`
`The complete deposition testimony is consistent with, and in no way contradicts, Dr.
`
`Brantigan’s testimony on this subject in paragraphs 10 to 14 of his second declaration.
`
`Response to Observation Nos. 4-6
`
`
`
`In Observations 4 and 5, Patent Owner discusses the capabilities of nubs to resist
`
`motion. Patent Owner asserts that Dr. Brantigan’s deposition testimony is “somewhat
`
`muted’ compared to his second declaration. By using this “somewhat muted” language,
`
`Patent Owner is admitting that no contradiction exists between the deposition testimony and
`
`declaration.
`
`In Observation 6, Patent Owner again takes snippets of testimony out of context and
`
`ignores the declaration testimony that shows Patent Owner’s mischaracterization of Dr.
`
`Brantigan’s testimony. In particular, Patent Owner ignores the citation in paragraph 18 of
`
`the declaration that references other paragraphs in the declaration and which fully explain
`
`how the ratchetings function differently during insertion and after implantation.
`
`In the case Observations 4-6, a simple review of Dr. Brantigan’s full testimony—
`
`rather than the cropped quotes provided by Patent Owner—confirms that no contradiction
`
`exists.
`
`
`
`
`
`4
`
`
`
`Case IPR2013-00395
`Attorney Docket No: 13958-113IP1
`
`Response to Observation No. 7
`
`
`
`In this Observation, Patent Owner discusses Dr. Brantigan’s testimony regarding
`
`whether it would be obvious to add ratchetings to an implant with convex upper and lower
`
`surfaces. Dr. Brantigan has always said that it would be obvious to make this combination
`
`[See, e.g., Ex. 1001 at ¶ 38; Ex. 1017. at ¶¶ 4-9] and Patent Owner does not cite any
`
`testimony to the contrary. Patent Owner’s argument that this testimony is contradicted by
`
`the absence of a disclosure of the claimed combination of features in Dr. Brantigan’s
`
`implant patents has no force. Moreover, the argument is belied by Dr. Brantigan’s
`
`observation that even the ‘696 patent does not disclose any embodiment with the claimed
`
`combination of features. Ex. 1017 at ¶ 29.
`
`Response to Observation Nos. 8 -12
`
`
`
`In these Observations, Patent Owner disagrees with Dr. Brantigan’s declaration
`
`testimony describing how Patent Owner mischaracterized Dr. Brantigan’s deposition
`
`testimony. A review of the relevant testimony fully supports Dr. Brantigan’s contention that
`
`Patent Owner mischaracterized his deposition testimony.
`
`
`
`5
`
`
`
`Case IPR2013-00395
`Attorney Docket No: 13958-113IP1
`Respectfully submitted,
`
`
` /Stephen R. Schaefer, Reg. No. 37,927/
`Stephen R. Schaefer
`Reg. No. 37,927
`
`
`
`
`
`
`
`
`
`
`
`
`
`Date: July 10, 2014
`
`
`Customer Number 26171
`Fish & Richardson P.C.
`Telephone: (612) 337-2508
`Facsimile: (612) 288-9696
`
`6
`
`
`
`Case IPR2013-00395
`Attorney Docket No: 13958-113IP1
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies that on
`
`July 10, 2014, a complete and entire copy of this PETITIONER’S RESPONSE TO THE
`MOTION FOR OBSERVATION REGARDING CROSS-EXAMINATION OF DR.
`BRANTIGAN was provided via email to the Patent Owner by serving the correspondence
`email addresses of record as follows:
`
`Thomas H. Martin
`Wesley C. Meinerding
`Martin & Ferraro, LLP
`1557 Lake O’Pines Street, NE
`Hartville, OH 44632
`
`Email: tmartin@martinferraro.com
`Email: docketing@martinferraro.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Edward G. Faeth/
`
`Edward G. Faeth
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(858) 678-5667
`
`
`
`7
`
`